AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares
The Boards of AbbVie (NYSE: ABBV) and Shire (NASDAQ: SHPQ) announced Friday, that they have reached agreement on the terms of a recommended merger of the two pharmaceutical companies. Under the terms of the merger, Shire Shareholders will be entitled to receive for each Shire Share £24.44 in cash and 0.8960 New AbbVie Shares. Both Boards have approved the transaction. The New AbbVie Shares are expected to be listed on the New York Stock Exchange.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.